This biopharmaceutical company develops and commercialises various products designed to treat central nervous system diseases, including schizophrenia, insomnia, and Parkinson’s disease.
This biopharmaceutical company develops and commercialises various products designed to treat central nervous system diseases, including schizophrenia, insomnia, and Parkinson’s disease.